# Novo Nordisk launches insulin pen production line in Iran

Novo Nordisk launched an insulin pen production line in Iran, the first of its kind in West Asia and East Mediterranean region. The project involved an investment of €70 million and is expected to create at least 150 jobs, producing up to 25 million insulin pens in the first year.

- Type: New facility
- Announced: 2020-08-31
- Where: Iran, Iran
- Value: $83.0M (70.0M EUR)
- Jobs: 150
- Starts operating: 31 Aug 2020
- Status: completed
- Capacity: 25 million insulin pens per year (first year), increasing to 45 million in second year
- Products: insulin pens
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [tehrantimes.com](https://www.tehrantimes.com/news/451878/Foreign-company-invests-70m-in-Iranian-medical-project), 2020-08-31: "Novo Nordisk, a leading global healthcare company, headquartered in Denmark, launched an insulin pen production line in Iran on Monday which is said to be the first of its kind in West Asia and East Mediterranean region."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.